Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Stryker

Explore full profile

Stryker - Medical Devices & Equipment Manufacturing Company : Stryker

Kalamazoo, United StatesFounded 1941Health Tech & Medtech
Valuation $106B Market cap · 2026
Revenue $27B Latest reported FY
EBITDA $7.80B Latest reported FY

About Stryker

Stryker is a leading medical technology company specializing in the development and manufacturing of innovative medical devices and equipment. Serving healthcare professionals and institutions globally, Stryker operates in the medical technology market, providing products that enhance patient care and improve surgical efficiency. The company's business model revolves around the design, production, and sale of medical devices, including surgical equipment, neurotechnology, and orthopedic implants. Revenue is generated through the direct sale of these products to hospitals, clinics, and other healthcare facilities. Stryker's commitment to innovation and quality has positioned it as a key player in the medical technology industry, continually advancing healthcare solutions.

Source: Dealroom company data

At a glance

Status
Listed
Founded
1941
Headquarters
Kalamazoo, United States
Listing
IPO 1983
Employees
52,195
Open positions
None listed
Dealroom signal
71.5/100
Industry
Health
Sub-industry
Medical Devices
Sector
Health Tech & Medtech, Biotechnology, Neurology, DT and LS, observatoire healthtech
Technology
Hardware, Deep Tech
Business model
Manufacturing
Client focus
b2b
Investment activity
46 companies, latest Aug 2026
Capital deployed
$13M
Preferred round
ACQUISITION

Funding history

3 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
POST IPO EQUITY✓Other financing Feb 2023 $997K — Bison Wealth ↗
GRANT✓Other financing Sep 2019 — — Undisclosed —
Showing the latest 2 of 3 recorded eventsBook a demo for the full funding history →

Financials

Revenue, earnings and profit over time

Revenue, earnings and other financial measures where available. Years marked “E” are estimates.

YearRevenueGrowthEBITDAMarginProfitMarginR&D
2026 $27B +8.4% $7.8B 28.6% $4.9B 18.1% $1.6B
2025 $25B +11.2% $6.5B 25.8% $3.2B 12.9% $1.6B
2024 $23B +10.2% $6.7B 29.6% $3B 13.2% $1.5B
2023 $20B +11.1% $5B 24.2% $1.4B
2022 $18B +7.8% $4.2B 23%
2021 $17B +19.2% $3.8B 22.1%
2020 $14B — $3.1B 21.4%
Company filings, research estimates and Dealroom dataBook a demo for the full financial model →

Growth signals

Stryker website traffic

Latest recorded traffic for Stryker is 960K monthly website visits, up 71.4% over the last three months.

Latest monthly visits960K 3-month web change+71.4%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Zurimed TechnologiesZurich, SwitzerlandZurimed Technologies create revolutionary devices for ligament reconstruction $53Mvaluation AVS PulseAnn Arbor, United StatesA new device that shatters calcium and expands vessels in order to treat peripheral artery disease and coronary artery disease $435Mvaluation Inari MedicalAliso Viejo, United StatesMedical device company developing devices for the interventional treatment of cardiovascular diseases $4.9Bvaluation NICOIndianapolis, United StatesProvides surgeons with advanced technologies and the education for appropriate use of the technologies in the pursuit of standardizing a new level of care to improve patient outcomes $50Mvaluation care.aiOrlando, United StatesAn agile team of servant leaders bringing passion and technical talents to build AI platforms and advanced sensor technology to power more human healthcare $108Mvaluation Vertos MedicalAliso Viejo, United StatesAnd markets medical devices that are used for the treatment of common spinal diseases $140Mvaluation MOLLI SurgicalToronto, Canada ArtelonAtlanta, United StatesArtelon | United States | Tendon Ligament Reconstruction $80Mvaluation mfPHDWaco, United States SERF SASDécines-Charpieu, France Cerus EndovascularOxford, United KingdomDesigns and develops interventional neuroradiology devices and delivery systems $7.9Mvaluation Vocera CommunicationsSan Jose, United StatesMobile, Secure Communication | Vocera $3.1Bvaluation

Investors

2 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series B and later1 investor entered at this stage

  • Bison Wealth

Other known investors1 additional known investor

  • KKR
Team profiled 668 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 2 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
🇺🇸 United States · Kalamazoo HQ
Book a demo for the full country breakdown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Stryker on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Stryker’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.